Newsroom

HYE, Texas--(BUSINESS WIRE)--William Chris Vineyards has been named one of the World’s 50 Best Vineyards, earning a place among the most celebrated wine destinations in the world at Number 31 on the list. The Hill Country estate is the first and only Texas winery to make the list, marking a defining moment for Texas wine and its growing recognition on a global stage. Founded in 2008 by Bill Blackmon and Chris Brundrett, William Chris has become a leader in Texas wine through a “grown, not made”...

NEW YORK--(BUSINESS WIRE)--HSBC today announced the appointment of Jason Henderson as Chief Executive Officer for the United States, effective immediately. Henderson has served as Interim CEO since August 2025, leading the business with a focus on client partnership, disciplined execution, and collaboration across HSBC’s global network. Henderson will report to Michael Roberts, CEO of HSBC Bank plc, and CEO of Corporate and Institutional Banking. Henderson will continue as a member of the Board...

LONDON--(BUSINESS WIRE)--        The Minster Building 21 Mincing Lane London EC3R 7AG     Tel 020 7862 6500   www.dmo.gov.uk     9 December 2025   PRESS NOTICE AUCTION OF BRITISH GOVERNMENT STOCK Auction Details Auction Date Tuesday, 16 December 2025 Issue and Settlement Date Wednesday, 17 December 2025 Bidding Convention Fully paid Bid Price (see Note 1) Accrued Interest payable with bid £0.615331491713 per £100 nominal Auction Open 9:00am London Time Auction Close 10:00am London Time Post Auc...

PHOENIX--(BUSINESS WIRE)--Fennemore, one of the fastest-growing Am Law 200 firms in the country, is celebrating 140 years of advancing what’s next in the legal profession. The firm is looking ahead—building new technologies, investing in its people, and creating solutions that help today’s businesses move forward. Founded in 1885 in the Arizona Territory with just two lawyers, the firm has grown to 375 attorneys across 65 cities nationwide. That growth has been driven by the same resourcefulnes...

ATLANTA--(BUSINESS WIRE)--Silicon Creations, a leading provider of high-performance analog and mixed-signal IP today announced the successful validation of interoperability of Chip Interfaces’ JESD204B, JESD204C, Interlaken, and CPRI controllers with its Multi-Protocol SerDes PMA(s). This achievement was realized through Chip Interfaces’ controllers being loaded into an FPGA interfacing with a test board containing Silicon Creations’ SerDes PMA in packaged silicon. Testing took place at Silicon...

MILL VALLEY, Calif,--(BUSINESS WIRE)--NASRC launches the FRIP Workforce Development Initiative to address California’s shortage of qualified refrigeration technicians....

LONDON & NEW YORK--(BUSINESS WIRE)--EDITED releases its 2025 Black Friday analysis, offering a data-driven look at key pricing and promotional trends across the US and UK....

DALLAS--(BUSINESS WIRE)--SmartMoving, the leading profitability platform for moving companies, has been named to Inc. Magazine’s 2025 Best in Business list in the Innovation category. The award honors companies making a meaningful difference in their industries, and for SmartMoving, that difference is profit visibility. SmartMoving was recognized for launching Smart Insights, the only business intelligence platform built specifically for movers. Unlike generic reporting tools, Smart Insights is...

DUBLIN--(BUSINESS WIRE)--The "Peptide and Oligonucleotide CDMO Market Forecast to 2033" has been added to ResearchAndMarkets.com's offering. The global peptide and oligonucleotide CDMO market is witnessing robust growth, with its valuation projected to leap from USD 2.80 billion in 2024 to USD 8.14 billion by 2033, achieving a CAGR of 12.75% from 2025 to 2033. This growth is attributed to the escalating demand for complex and targeted therapeutics, the surge in investments in biologics and nucl...

カリフォルニア州サンカルロス--(BUSINESS WIRE)--（ビジネスワイヤ） -- グローバルなオンコロジー企業であるBeOne Medicines Ltd.（Nasdaq: ONC; HKEX: 06160; SSE: 688235）は、フロリダ州オーランドで開催される第67回ASH年次総会・展示会において、血液領域のポートフォリオの深み、質、勢いを示すことで、慢性リンパ性白血病（CLL）におけるイノベーションのリーダーという同社の立場を改めて示します。BeOneのASHデータ全体は、BRUKINSA ®（ザヌブルチニブ）が、ブルトン型チロシンキナーゼ阻害薬（BTKi）の基盤となる選択肢であることを裏付けています。 「ASH 2025では、BRUKINSAの強みとBGB-16673の可能性の両方を浮き彫りにする、当社のCLLフランチャイズ全体にわたる新たなデータを発表します」と、BeOneの血液領域チーフ・メディカル・オフィサー（CMO）であるアミット・アガルワル医学博士は述べています。「CLLにおいては長期データがゴールドスタンダードであり、BRUKINSAは、患者と医師...